Biotech Startup Aureka Raises $100M Series B
Aureka Biotechnologies is convinced that artificial intelligence can speed up drug discovery. Its $100 million Series B round has pushed total funding to nearly $200 million, giving the young company the backing to move its AI drug-discovery platform …